New hope for Parkinson's patients through stem cell technology?

©BlueRocks Therapeutics


	New hope for Parkinson's patients through stem cell technology? A contribution by Jürgen Zender

An innovative procedure from stem cell medicine could alleviate symptoms in Parkinson's patients in the future. The researchers rely on lab-grown neurons that are inserted into the brains of patients to produce the essential neurotransmitter dopamine.

Novelty of the procedure:
– Using neurons from the lab to produce dopamine in the brain.
– Neurons created using embryonic stem cell technology are designed to form synapses and behave like their own brain cells.
– The aim of the procedure is to reduce the devastating symptoms of Parkinson’s, mainly movement problems.

Researchers hope:

- Initial data indicate that the implanted cells survive one year after treatment and reduce patients' symptoms.
- Brain scans showed an increase in dopamine cells in the brain and a decrease in what is known as off-time in patients.

Criticism of the researchers' optimism:

– Experts advise caution when interpreting the results due to possible inconsistent effects and potential placebo effect.
– It is not possible to directly observe the implanted brain cells.
- The mere fact that transplanted cells survived is not enough to confirm the actual benefit or effectiveness of the treatment.

Summary

Punkt	Details
Novelty of the procedure	– Laboratory grown neurons – Production of dopamine – Integration like your own brain cells
Hope of the researchers	- Survival of the implanted cells – Reduction of symptoms
Criticism of the researchers' optimism	– Inconsistent effects – Potential placebo effect - Difficulty observing implanted cells
Additional Information	– Study funded by BlueRock Therapeutics – Care should be taken when interpreting the results

More articles from the category " Research and Development"

29 April 2024 / To know better, Research and Development, Prasinezumab, Therapies

Can prasinezumab slow the progression of motor symptoms?

An article originally published in the Ärzteblatt is about the effect of the drug prasinezumab on motor symptoms. In a clinical trial, it was observed that the placebo group experienced a severe deterioration...

20 April 2024 / To know better, Entrance therapy, info event, Professor Weise, Guides, Video

Diagnosis of Parkinson's and the correct initial therapy

Parkinson's is a neurological disease that affects the lives of millions of people worldwide, whether directly as sufferers or indirectly as relatives, carers or medical professionals. In this lecture...

18 April 2024 / To know better, info event, Professor Ceballos-Baumann, Guides, nice clinic, Video

Introduction to the world of Parkinson's - a lecture by Prof. Dr. Ceballos Baumann

10 April 2024 / To know better, Cdnf, Research and Development, Neuroprotective, Protein

The hope for a new era in Parkinson's treatment: CDNF in focus

The world of medicine may be on the verge of a revolutionary development in the fight against Parkinson's disease, thanks to the discovery and research surrounding a special protein known as cerebral dopamine...

8 April 2024 / Alpha synuclein, To know better, Biopsy, Research and Development, Skin test, Levi corpuscle

The skin as a mirror of the brain

We all know the skin as the largest organ in our body - it protects us, regulates temperature and enables touch. But did you know that the skin now also...

3 April 2024 / To know better, early in the, info event, Impede, delay stop, Video

Detect Parkinson's early, delay it, stop it or prevent it

In his lecture “Detect, delay, stop or prevent Parkinson’s disease early” Professor Oertel shares his extensive knowledge and many years of experience with us. Parkinson's disease, a progressive neurodegenerative disease, affects...

Do you already have the Parkinson's Journal app?

The PJApp is available for a one-time fee of €2,89 and includes a lifetime subscription right.

And the best part is: The income from the sale of the App 50% will be donated to PingPongParkinson, 25% will go into a reserve around that Parkinson Journal at the turn of the year into a non-profit publishing company and only 25% serve to cover costs.

Especially for all those who are not yet ready to join a self-help group, we as a magazine would like to Window for Parkinson- be world. As victims, we know that Parkinson has become an unexpected companion in our lives. We want to show appreciation to these people and inform them with heart and mind. We want to show them that they are not alone and that there is hope and support.

By purchasing the app, you can support us on this journey.

You get the app at google play or im App Store